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and Hong Guo1*Abstract
The gene encoding diacylglycerol acyltransferase (DGAT1) is a functional and positional candidate gene for milk and
intramuscular fat content. A bovine DGAT1 overexpression vector was constructed containing mouse MCK
promoter and bovine DGAT1 cDNA. MCK-DGAT1 transgene in FVB mice was researched in present study. The
transgene DGAT1 had a high level of expression in contrast to the endogenous DGAT1 in posterior tibial muscle of
the transgenic mice, but a low expression level in the cardiac muscle. Compared with wild-type mice, triglyceride
and DGAT1 content were approximately fourfold and 50% increased in posterior tibial muscle of the transgenic
mice, respectively, while a little increase in cardiac muscle.
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Triacylglycerols (TG) are quantitatively the most import-
ant storage form of energy for eukaryotic cells. Diac-
ylglycerol acyltransferase 1 (DGAT1) encodes acyl CoA:
diacylglycerol acyltransferase (DGAT) which catalyzes
the terminal and only committed step in triacylglycerol
synthesis [1]. DGAT1 is present in all cell types but is
most highly expressed in tissues and organs where trigly-
ceride synthesis is most active, including adipose tissue,
liver, skeletal muscle and small intestine. Bovine DGAT1
spaning 14117 base pairs (bp) was assigned to a region
on bovine chromosome 14 close to the centromere and
contains 17 exons and 16 introns [2]. Its coding sequence
(CDS) spans 1470 bp and encodes 489 amino acids. DGAT
deficiency alters triglyceride metabolism in mammary
gland of mice [3]. Thaller et al. [4] treated DGAT1 as a
positional and functional candidate gene for intramuscular
fat deposition in cattle. Myocellular overexpression of
DGAT1 resulted in increased intramyocellular TG levels
but decreased myocellular DAG and ceramide levels [5].
Muscle creatine kinase (MCK) is critical to the energy
metabolism of skeletal muscle as the key enzyme in the* Correspondence: gpengli@imu.edu.cn; guohong882003@aliyun.com
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reproduction in any medium, provided the orphosphorylcreatine shuttle between mitochondria and
the myofibrils [6]. The MCK gene is transcriptionally ac-
tivated during striated muscle differentiation and is
expressed at high levels in skeletal and cardiac muscles.
Transcriptional regulation of the gene in cultured skel-
etal and cardiac muscle cells has been shown, as well as
in transgenic mice [7]. Jaynes et al. [8] demonstrated a
3.3 kilobases (kb) 5′-flanking region of the MCK gene
which was sufficient to confer transcriptional regulation
to a heterologous structural gene (chloramphenicol acetyl
transferase). The major effector of high-level expression
was found to have the properties of a transcriptional en-
hancer. This element, located between 1050 and 1256 bp
upstream of the transcription start site, activated either
the MCK promoter or heterologous promoters in differ-
entiated muscle cells [9]. Besides the 206 bp MCK enhan-
cer, the 1 kb region of DNA between the enhancer and
the basal promoter is essential for the transgenic expres-
sion in skeletal muscle ,unlike its behavior in cell culture
[10]. Long terminal repeat (LTR) inserted with MCK en-
hancers was utilized by Wang et al. [11] to increase hu-
man factor IX (FIX) expression in skeletal muscle cells
in vitro and in vivo.
In the present study, we wanted to investigate whether
bovine DGAT1 could express in skeletal muscle of mice
under the control of mouse MCK promoter, and deter-
mine the effect of bovine DGAT1 overexpression ond. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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genic mice.
Results
Overexpression of DGAT1 in skeletal muscle of MCK-
DGAT1 transgenic mice
We used the 1.38 kb mouse MCK promoter, which is
widely used for skeletal and cardiac muscle transgene ex-
pression, to direct the expression of a full-length bDgat1
cDNA. The RT gene expression analysis was performed
on five transgenic mice and five WT mice, which showed
that expression of the transgene was primarily restricted
to skeletal muscle, and had a high level contrast to the en-
dogenous DGAT1 in posterior tibial muscle of the trans-
genic mice (Figure 1A), but a very low expression level in
the cardiac muscle (Figure 1B). Gene expression in one
WT mice were showed in Figure 1C and Figure 1D.
Increased TG and DGAT1 content in skeletal muscle of
MCK-DGAT1 transgenic mice
10 – 12 weeks mice were used in this study. No signifi-
cant difference in body weight was detected between the
transgenic (19.57 ± 1.04 g) and WT (20.03 ± 1.31 g) mice.
TG levels in posterior tibial muscle were approximately
fourfold increased in MCK-DGAT1 mice compared with
WT mice (Figure 2A). A approximately 50% increase in
total DGAT content was observed in posterior tibial
muscle of the transgenic mice, compared with WT mice
(Figure 2B). TG (Figure 2C) and DGAT1 (Figure 2D)Figure 1 Expression level of endogenous DGAT1 and transgene in fiv
muscle of one transgenic mice. (B) Expression in cardiac muscle of one transg
(D) Expression in cardiac muscle of one WT mice. (1) The expression of Gapdh
transgene DGAT1.content in cardiac muscle of MCK-DGAT1 mice were
only a little higher than that of WT mice.Discussion
MCK-DGAT1 transgenic mice were healthy and fertile.
The present study shows that bovine DGAT1 could ex-
press in skeletal muscle of mice under the control of
mouse MCK promoter, and overexpression of DGAT1
resulted in increased TG levels in skeletal muscle of mice,
while the influence of transgene on cardiac muscle was
low. Liu et al. [5] demonstrated similar results in skeletal
muscles including gastrocnemius, soleus, and posterior tib-
ial muscles, and heart. Their results also showed the effect
of DGAT1 on muscle insulin sensitivity and that DGAT1
transgenic mice were resistant to HFD (high fat diet) – in-
duced obesity. Thus, the overexpression of DGAT1 is the-
oretically a possible means to protect the healthy of
transgenic animals while increasing intramuscular fat.
Intramuscular fat (percentage of lipid content of muscle),
also subjectively assessed as marbling, represents an im-
portant beef quality trait [4]. The MCK-DGAT1 transgene
is expected to applying in bovine to improve the quality of
beef. In the subsequent study, we will investigate whether
the mouse MCK promoter works in bovine.
Liu et al. [12] first demonstrated in vivo that although
skeletal muscle of MCK-DGAT1 mice was more resist-
ant to developing HFD-induced lipotoxicity, their liver
was as susceptible for lipotoxic insulin resistance as that
of wild-type mice. In our study, fatty liver was note transgenic mice and five WT mice. (A) Expression in posterior tibial
enic mice. (C) Expression in posterior tibial muscle of one WT mice.
. (2) The expression of endogenous DGAT1. (3) The expression of
Figure 2 TG and DGAT1 levels in posterior tibial and cardiac muscle of MCK-DGAT1 mice and WT mice. (A) TG content in posterior tibial
muscle of MCK-DGAT1 mice (190.05 ± 13.17 nmol/mg) was significantly higher than that of WT mice (56.36 ± 2.29 nmol/mg, P<0.01). (B) DGAT1
content in posterior tibial muscle of MCK-DGAT1 mice (0.129 ± 0.011 ng/mg) was significantly higher than that of WT mice (0.087 ± 0.002 ng/mg,
P<0.01). (C) TG content in cardiac muscle of MCK-DGAT1 mice (16.21 ± 2.14 nmol/mg) was significantly higher than that of WT mice (12.00 ± 0.09
nmol/mg, P<0.01). (D) DGAT1 content in cardiac muscle of MCK-DGAT1 mice (0.091 ± 0.004 ng/mg) was significantly higher than that of WT mice
(0.072 ± 0.004 ng/mg, P<0.01).
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performed in subsequent study.Methods
Generation of MCK-DGAT1 transgenic mice
The transgene contains, from the 5′-end to the 3′-end,
an 1.38 kb mouse MCK promoter, and an 1.48 kb full-
length bovine DGAT1 (bDGAT1) cDNA (Figure 3).
Transgenic mice were produced by pronuclear injection
of FVB fertilized eggs with the transgene. Genotyping
was carried out by PCR using genomic DNA extracted
from mouse tails. The PCR was performed with primers
F (5′- GATCCCCTATGGTGCACTCT -3′) and R (5′-
TACGTCTCCGTCCTTGTCTG -3′) that amplified an
1.8 kb fragment in MCK-DGAT1 mice.Figure 3 The MCK-DGAT1 transgene. The transgene contains,
from the 5′-end to the 3′-end, an 1.38 kb mouse MCK promoter, and
an 1.48 kb full-length bovine DGAT1 (bDGAT1) cDNA.Test conditions
Wild-type (WT) mice were purchased. Mice were housed
in a barrier facility with 12-hour light/12-hour dark cycles
and fed normal chow.
Reverse transcriptase PCR
Total RNA was extracted from cardiac and posterior
tibial muscle using TRIzol Reagent purchased from
Invitrogen. The muscle were first homogenized with
TRIzol Reagent, then RNA was separated in chloroform,
precipitated by isopropanol, and washed by 75% etha-
nol, lastly the RNA was dissolved in RNase-free water.
Total RNA was reverse-transcribed into cDNA which was
used in the subsequent PCR amplification. The mRNA
levels were quantified using the following primers: mouse
endogenous DGAT1, forward, 5′- GCCCAAGGTAGA
AGAGGACGAG-3′, reverse, 5′- AGTATGATGCCAGA
GCAAACACG-3′, PCR temperature program, 95°C
3 min, then 95°C 30 s, 59°C 30 s, 72°C 30 s for 30 cycles,
72°C 5 min; transgene DGAT1, forward, 5′- AGAGGA
GGTGCGGGATGTGG-3′, reverse, 5′- TCGCGGTA
GGTCAGGTTGTCG-3′, PCR temperature program,
95°C 3 min, then 95°C 30 s, 61°C 30 s, 72°C 30 s for 30
cycles, 72°C 5 min. mRNA levels were then expressed as
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test, forward, 5′- GATGCCCCCATGTTTGTGAT-3′,
reverse, 5′- GGGTGGTCCAGGGTTTCTTA-3′, PCR
temperature program, 95°C 3 min, then 95°C 30 s, 54°C
30 s, 72°C 30 s for 30 cycles, 72°C 5 min. The RT gene
expression analysis was performed on five transgenic
mice and five WT mice.
TG content
Tissues were homogenized by pestles in isoamyl alcohol.
Triglyceride mass in lipid extracts was enzymatically de-
termined with a colorimetric kit.
DGAT1 content
Tissues were homogenized by pestles in PBS. Total
DGAT1 content was measured with a DGAT1 ELISA
kit. Double antibody sandwich ELISA is used in this kit
to measure the content of DGAT1 in tissue homogenate
quantitatively.
Statistical analysis
Data were expressed as means ± SD. Statistical differences
were analyzed by ANOVA to determine overall treatment
effects including TG and DGAT1 content (SPSS 11.0). A
two-tailed P value of 0.01 was used to indicate statistical
significance.
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